GlassScriptPhysician profile
Imran R Sheikh
NPI 1225118235
$15,094.35
in general payments reported to CMS, 2019-2025
31 companies · $2,551 in 2025
The $2,551 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $885 · 2021: $2,565 · 2022: $1,132 · 2023: $5,402 · 2024: $2,559 · 2025: $2,551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,290 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Travel and Lodging: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,290.35 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Travel and Lodging | $221.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,867.19 | 2021-2025 | Watchman Flx, Rhythmia Mapping System, Varithena Administration Pack |
| Medtronic, INC. | $3,478.87 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Pulseselect |
| Biosense Webster, INC. | $2,295.97 | 2022-2025 | Carto 3, Nuvision Ice Catheter |
| Medtronic Vascular, INC. | $885.35 | 2019 | |
| Abbott Laboratories | $882.82 | 2022-2025 | Aveir, Jeti, Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $606.62 | 2021-2025 | Lifevest |
| Aop Health US, LLC | $440.43 | 2025 | Rapiblyk |
| Pfizer INC. | $330.68 | 2022-2025 | |
| Abiomed | $302.17 | 2023-2024 | Impella |
| E.R. Squibb & Sons, L.L.C. | $263.46 | 2021-2025 | Camzyos, Eliquis |
| Atricure, INC. | $254.15 | 2023 | |
| Biotronik INC. | $221.42 | 2021-2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Cleerly, INC. | $180.34 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Cardiva Medical, INC. | $157.45 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Amgen INC. | $140.41 | 2021-2023 | Repatha |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $130.55 | 2022-2025 | |
| Edwards Lifesciences Corporation | $106.39 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kestra Medical Technology Services, INC. | $105.57 | 2023-2025 | Assure Wcd |
| Cvrx, INC. | $96.04 | 2022 | |
| Pinnacle Biologics, INC | $70.15 | 2022-2023 | Photofrin |
| Novo Nordisk INC | $47.62 | 2023-2025 | Ozempic, Wegovy |
| Sanofi-Aventis U.S. LLC | $33.87 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $29.17 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $29.15 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $26.84 | 2022 | |
| Philips North America LLC | $26.48 | 2024 | (Cm9) Amb Mon & Diag Und |
| Amarin Pharma, INC. | $19.93 | 2022 | |
| Alnylam Pharmaceuticals INC. | $19.53 | 2025 | Amvuttra |
| Janssen Pharmaceuticals, INC | $17.35 | 2024 | Xarelto |
| Esperion Therapeutics, INC. | $14.60 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Sheikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.